Systemic Immune Inflammatory Index in Systemic Lupus Erythematosus
Recruiting · NCT06796569 · Observational (researchers observe without assigning treatment) · Lead sponsor: Sohag University
View the official record on ClinicalTrials.gov →Interventions studied
systemic immune inflammatory index
What this trial is about
This study aims to investigate the association between the systemic immune-inflammation index and disease activity, as well as lupus nephritis in patients with systemic lupus erythematosus
Who can take part
Age range
16 Years and older
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- o Older than 16 years
- In a patient with SLE, patients who fulfill the criteria of the American College of Rheumatology (ACR) and European League Against Rheumatism (EULAR).
- In patients with LN, patients whose diagnosis is confirmed by kidney biopsy and pathohistological verification (WHO classification, and the International Society of Nephrology/Renal Pathology Society (ISN/RPS) classification.
Exclusion criteria
- Patients with other autoimmune rheumatological diseases, lymphoproliferative disorders, malignancies, liver diseases, end-stage kidney disease, diabetic nephropathy, active infections, recent history of blood transfusion and patients with deficiencies in vitamin B12, folate, and iron are excluded from the study.
Where it is running
1 location listed.
- Sohag Faculty - Sohag, Sohag Governorate, Egypt